Advertisement
Home 2017 October

Monthly Archives: October 2017

For male patients with cirrhosis

Visceral Adipose Tissue Index IDs Risk of HCC in Cirrhosis

0
High VATI is also linked to risk of HCC recurrence in males with HCC who underwent liver transplant
The increasing participation of men in registered nursing can be attributed to multiple factors

Men Now Comprise ~10 Percent of RN Workforce

0
About half of increase due to educational attainment, rising demand, liberalizing gender attitudes
Appropriate use criteria have been developed for the treatment of patients with severe aortic stenosis

Appropriate Use Criteria Developed for Aortic Stenosis Tx

0
SAVR or TAVR appropriate for most patients with symptomatic AS at intermediate or high surgical risk
Overall survival for patients with melanoma brain metastases has improved significantly since 2000

Overall Survival Up for Melanoma Brain Metastases

0
Median overall survival from time of diagnosis has increased from 7.5 to 22.7 months
Serum tau is a promising novel biomarker for prediction of neurological outcome in patients with cardiac arrest

Tau May Predict Neurological Outcome After Cardiac Arrest

0
Increased serum tau is associated with worse outcome six months after cardiac arrest
Oral semaglutide is associated with better glycemic control than placebo among type 2 diabetes patients with insufficient glycemic control

Glycemic Control Up With Oral Semaglutide in Type 2 Diabetes

0
Phase 3 studies next to assess longer-term/clinical outcomes, safety
Physicians should make a public commitment to speak with their patients about firearms

Doctors Urged to Speak With Patients About Firearms

0
Making a public commitment is encouraged as a positive action that physicians can take
A machine learning model can predict the risk of upgrade of high-risk breast lesions to cancer

Machine Learning Model Predicts Risk of Upgrade to Breast CA

0
Model can predict risk of upgrade of high-risk breast lesions to cancer using traditional, text features
Oral semaglutide is associated with better glycemic control than placebo among type 2 diabetes patients with insufficient glycemic control

Glycemic Control Up With Oral Semaglutide in Type 2 Diabetes

0
Phase 3 studies next to assess longer-term/clinical outcomes, safety
For males

Mortality Up for Male Recipients of Blood From Ever-Pregnant

0
Receipt of red blood cell transfusion from ever-pregnant donor tied to increased risk for males